Epidemiologie des Mamma - Karzinom | |||||||||||||||||||||
Inzidenz | BRD |
|
|||||||||||||||||||
Sachsen-Anhalt |
2007: 89 / 100.000 | ||||||||||||||||||||
USA |
2008: 184.450 Neuerkrankungen | ||||||||||||||||||||
Lebenszeitrisiko | BRD: 12% | ||||||||||||||||||||
Alter | Mittleres Erkrankungsalter 62 Jahre. |
BRD: 50% > 65a, 30% >70a. |
|||||||||||||||||||
Mortalität | Welt |
411.000 Sterbefälle pro Jahr | |||||||||||||||||||
USA |
2008: 40.930 Sterbefälle | ||||||||||||||||||||
BRD |
|
||||||||||||||||||||
Sachsen-Anhalt |
2007: 21,2 /100.000 | ||||||||||||||||||||
Praevention | |||||||||||||||||||||
Risikofaktoren | BRCA, ATM, RAD51C, E-Cadherin, HRT, Geburtsgewicht, Strahlenexposition, 25[OH] D, Schilddrüse | ||||||||||||||||||||
Quellen |
1.) Meindl A, et al.: Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nature Genetics April 2010 (EPublished first) 2.) Pharoah PD, et al.: Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 121(2001):1348–1353 3.) Muller I, et al.: High prevalence of breast cancer in patients with benign thyroid diseases. J Endocrinol Invest 34(2011):349-352 |
||||||||||||||||||||
Teil von |
Mamma - Karzinom | Gynäkologische Onkologie | |||||||||||||||||||
Impressum Zuletzt geändert am 08.03.2014 18:59